This evidence supports the finding that sleep disorders occur in patients who have not been given IFN-α and suggests that they are caused by altered levels of this cytokine, indicating that continued exposure to cytokines and innate immune molecules, such as IFN-α, reduce sleep continuity and induce a pattern that is consistent with insomnia and arousal. The gene discussed is IFNA1; the disease is insomnia measurement.